TerminatedPhase 4

Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.

Stopped: COVID-19 pandemic and philips cpap machine recall

Brazil150 participantsStarted 2019-04-01

Plain-language summary

Despite the advances in the treatment of acute cardiogenic pulmonary edema (ACPE), the readmissions rates and cardiovascular events remain very high. In this context, it is possible that other potential risk factors may influence the poor prognosis of the ACPE. One of these potential candidates is Obstructive Sleep Apnea(OSA). This study was designed to evaluate the impact of OSA treatment with CPAP in consecutive patients with ACPE. The primary outcome will be to evaluate the impact of CPAP on the recurrence of ACPE in the 1-year follow-up.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hypertensive acute Cardiogenic Pulmonary Edema * Moderate to Severe OSA Exclusion Criteria: * Professional drivers * Pregnancy * Non-Cardiogenic Pulmonary edema * Terminal cancer

What they're measuring

Rate of ACPE recurrence

Timeframe: 1-year

Trial details

NCT IDNCT03936751

SponsorUniversity of Sao Paulo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-31

View on ClinicalTrials.gov More Obstructive Sleep Apnea trials